Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Organicell Regenerative Medicine Inc (OCEL)

Organicell Regenerative Medicine Inc (OCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID PR Newswire - Thu Nov 17, 2022

/PRNewswire/ -- Research and development is still focused on trying to help understand the acute infection 9itself and the effects of long COVID as well. As...

OCEL : 2.7500 (unch)
RGNX : 15.90 (+1.66%)
SBFM : 1.2100 (-15.97%)
ABBV : 169.54 (+0.98%)
RVNC : 3.66 (+0.55%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID FinancialNewsMedia - Thu Nov 17, 2022

Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the...

SBFM : 1.2100 (-15.97%)
ABBV : 169.54 (+0.98%)
OCEL : 2.7500 (unch)
RGNX : 15.90 (+1.66%)
RVNC : 3.66 (+0.55%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 FinancialNewsMedia - Tue Nov 15, 2022

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 46.42 (+2.29%)
OCEL : 2.7500 (unch)
BRTX : 1.3400 (-2.90%)
MDXG : 6.51 (+2.36%)
NNVC : 1.1400 (+1.79%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 PR Newswire - Tue Nov 15, 2022

/PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one...

OCEL : 2.7500 (unch)
BRTX : 1.3400 (-2.90%)
MDXG : 6.51 (+2.36%)
NNVC : 1.1400 (+1.79%)
VCEL : 46.42 (+2.29%)
BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster Business Wire - Wed Sep 14, 2022

The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced a collaboration with biotech company Organicell to co-create a first-to-market exosome booster that will address...

SKIN : 3.22 (-1.53%)
OCEL : 2.7500 (unch)
Organicell Announces Matt Sinnreich as CEO AccessWire - Tue Jul 26, 2022

MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological...

OCEL : 2.7500 (unch)
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management AccessWire - Wed Jul 20, 2022

MIAMI, FL / ACCESSWIRE / July 20, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological...

OCEL : 2.7500 (unch)
Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients AccessWire - Tue Feb 8, 2022

MIAMI, FL / ACCESSWIRE / February 8, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced...

OCEL : 2.7500 (unch)
Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities AccessWire - Wed Dec 29, 2021

MIAMI, FL / ACCESSWIRE / December 29, 2021 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, is pleased...

OCEL : 2.7500 (unch)

Barchart Exclusives

3 Overlooked Stocks to Buy This Spring Barchart - 13 minutes ago
With mid-cap stocks anticipated to make a comeback on accelerated earnings growth, here are three overlooked stocks that investors might consider this spring. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot